Richmond, Jan. 04, 2024 (GLOBE NEWSWIRE) -- According to a research report "DNA and Gene Cloning Services Market”, By Product Type (Custom Cloning, Gene Synthesis, Sub-cloning, Others), Application (DNA Sequencing, Genotyping, Mutagenesis, Others), End-user (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Others) and Region - Global Forecast to 2030.
Global DNA and Gene Cloning Services Market Report Scope:
| Report | Details |
| Market size value in 2023 | USD 3.02 Billion |
| Market size value in 2030 | USD 7.84 Billion |
| CAGR (2023-2030) | 14.6% |
| Forecast Period | 2023–2030 |
| Historic Data | 2019 |
| Forecast Units | Value (USD Million/USD Billion) |
| Segments Covered | Product Type, Application, End User and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and RoW |
| |
| |
| Sample of Companies Covered |
|
| |
|
Download the Sample - https://www.marketdigits.com/request/sample/3785
TOC Covers in Depth & Breath on DNA and Gene Cloning Services Market
170 - Market Data Tables
65 - List of Figures
225 – Pages
The report includes Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Developments, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional FootPrint by MarketDigits.
Market Overview
The DNA and Gene Cloning Services Market has emerged as a pivotal sector within the biotechnology industry, driven by the increasing demand for personalized medicine, advancements in gene therapy, and the expansion of genetic research. This market encompasses a wide range of services, including DNA sequencing, gene synthesis, and gene cloning, which play crucial roles in understanding and manipulating genetic material. The rising prevalence of genetic disorders and the growing need for targeted therapeutics have fueled the demand for DNA and gene cloning services. Key players in the market offer comprehensive solutions, from custom gene synthesis to plasmid preparation, enabling researchers and pharmaceutical companies to accelerate their genomic studies and drug development processes. Additionally, advancements in gene editing technologies, such as CRISPR-Cas9, have further propelled the market forward, opening new avenues for precision medicine and biotechnological innovations. The DNA and Gene Cloning Services Market is poised for continuous growth as the fields of genomics and genetic engineering continue to evolve, presenting opportunities for both established companies and new entrants to contribute to groundbreaking discoveries and therapeutic advancements.
Major vendors in the global DNA and Gene Cloning Services Market:
- Aragen Life Sciences
- Bio-Techne
- Charles River Laboratories
- Curia
- Eurofins
- GenScript
- Integrated DNA Technologies
- MedGenome
- Sino Biological
- Syngene
- Twist Bioscience
Request for Discount @ https://www.marketdigits.com/request/discount/3785
Advancements in gene editing technologies
Advancements in gene editing technologies, particularly exemplified by the revolutionary CRISPR-Cas9 system, stand as a key driver for the DNA and Gene Cloning Services Market. The precision, efficiency, and versatility of CRISPR-Cas9 have transformed the landscape of genetic engineering, allowing for targeted modifications in the DNA sequence with unprecedented accuracy. This breakthrough technology has not only accelerated research in functional genomics but has also facilitated the development of novel therapeutic interventions. As the demand for precise and tailored genetic modifications grows across various industries, including medicine, agriculture, and biotechnology, DNA and gene cloning services are increasingly sought after to harness the potential of these advanced gene editing tools. Companies offering cloning and sequencing services play a pivotal role in supporting researchers and biopharmaceutical companies in utilizing gene editing technologies for applications ranging from the study of gene function to the development of gene therapies. The continuous evolution of gene editing tools is thus propelling the growth of the DNA and Gene Cloning Services Market by providing scientists with powerful means to manipulate and understand the intricacies of the genetic code.
Market Dynamics
Drivers:
- Increasing demand for customized DNA constructs
- Growing personalized medicine and gene therapy
- Rising prevalence of chronic diseases
Opportunities:
- Advancements in automation and high-throughput platforms
- Increasing Investment In R&D
Increasing accessibility and affordability
A prominent trend in the DNA and Gene Cloning Services Market is the ongoing drive towards increasing accessibility and affordability of these services. Technological advancements, automation, and streamlined processes have significantly reduced the costs associated with DNA sequencing, gene synthesis, and cloning, making these services more accessible to a broader range of researchers, laboratories, and even smaller biotech startups. This trend is fostering a democratization of genomic research, enabling scientists with varying resource capacities to participate in cutting-edge studies. Moreover, the push for affordability has been catalyzed by the growing demand for personalized medicine and the need for cost-effective solutions in the development of gene therapies. As the market continues to mature, innovations in service delivery models and collaborations are likely to further enhance accessibility and affordability, ensuring that the benefits of DNA and gene cloning services are accessible across diverse scientific and medical communities. This trend aligns with the broader goal of advancing genetic research and therapeutic applications on a more inclusive and global scale.
North America dominates the market for DNA and Gene Cloning Services Market.
North America dominated the global DNA and gene cloning services market. This can be attributed to advancements in technology, strategic partnerships, and acquisitions within the biomedical and healthcare sectors. Notably, in December 2020, Thermo Fisher bolstered its clinical and commercial plasmid DNA manufacturing capabilities, exemplified by the establishment of a new cGMP facility in Carlsbad, California, U.S. This development is poised to accelerate the commercialization of plasmid-based drugs and vaccines, catering to the increasing demand in the market. The facility's capacity to produce significant quantities of plasmid DNA, a crucial component in DNA treatments, aligns with the company's commitment to providing comprehensive cell and gene therapy services. Furthermore, the prioritization of DNA and gene cloning in the life science research industry, coupled with substantial investments, funding, and collaborative initiatives, is expected to be a driving force for industrial growth throughout the forecast period.
DNA sequencing Segments is anticipated to hold the Largest Market Share during the Forecast Period
Based on the Application segment, the global DNA and gene cloning services market is categorized by application, including DNA sequencing, mutagenesis, genotyping, and other applications. The rapid evolution of sequencing technology and bioinformatics has significantly enhanced the identification of DNA variations, including those associated with an elevated risk of diseases. The DNA sequencing segment is particularly influenced by technological advancements, the proliferation of partnerships and collaborations among key industry players, and the expansion of global genome mapping initiatives. A notable example is the Whitehead Institute for Biomedical Research in Massachusetts, the U.S., which announced the installation of Illumina's NovaSeq 6000 Sequencing System in June 2020, underscoring the continuous efforts to integrate cutting-edge sequencing technologies into research centers. In 2020, professors David Klenerman and Shankar Balasubramanian made noteworthy contributions to the field by developing Next Generation DNA Sequencing technology. These developments collectively contribute to the growth and significance of the DNA sequencing segment within the broader DNA and gene cloning services market.
Inquire Before Buying: https://www.marketdigits.com/request/enquiry-before-buying/3785
Browse Similar Reports:
Cell and Gene Therapy CRO Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Preimplantation Genetic Testing Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Gene Synthesis Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
About MarketDigits:
MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.
We offer services that are most relevant and beneficial to the users, which help businesses to sustain themselves in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.
Contact Us:
MarketDigits
1248 CarMia Way Richmond,
VA 23235,
United States.
USA: +1 847 450 0808
Email: sales@marketdigits.com
Web: https://www.marketdigits.com
Follow Us on: | Twitter | LinkedIn |
